Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Oliveira JFP et al. - AKI was frequent among ICU patients receiving an aminoglycoside, and it was associated with a high rate of mortality. The presence of diabetes or hypotension and the use of other nephrotoxic drugs and iodinated contrast were independent risk factors for the development of aminoglycoside-associated nephrotoxicity.

Related Articles

Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
European Journal of Cancer, 10/23/09    Relevance Score: 85%

What I tell my patients about contrast medium nephrotoxicity
British Journal of Renal Medicine, 10/27/09    Relevance Score: 82%

Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children
Journal of Clinical Oncology, 10/26/09    Relevance Score: 82%

Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells
American Journal of Physiology: Renal Physiology, 11/12/09    Relevance Score: 80%

Renal Dendritic Cells Ameliorate Nephrotoxic Acute Kidney Injury
Journal of the American Society of Nephrology, 11/04/09    Relevance Score: 80%

Today in Pharmacology/kinetics...keeping you current

Medium-size-vessel vasculitis
Pediatric Nephrology, 12/04/09

Sirolimus and Cyclosporine A Alter Barrier Function In Renal Proximal Tubular Cells through Stimulation of ERK 1/2 Signaling and Claudin-1 Expression
American Journal of Physiology: Renal Physiology, 12/04/09

Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation
Urologic Oncology: Seminars and Original Investigations, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address